营收净利双增【福元_老虎社区_美港股上老虎

营收净利双增
【福元医药：上半年归母净利润2.91亿元，同比增16.1%】福元医药8月14日发布2024年半年度报告，公司2024年上半年实现营业收入16.55亿元，同比增长1.58%；归属于上市公司股东的净利润2.91亿元，同比增长16.10%；基本每股收益0.61元。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":338692608860384,"tweetId":"338692608860384","gmtCreate":1723692940601,"gmtModify":1723692942930,"author":{"id":3488157435400312,"authorId":3488157435400312,"authorIdStr":"3488157435400312","name":"GPLP","avatar":"https://static.tigerbbs.com/3d7067ce030a0ec14155582602e3b00a","vip":6,"userType":6,"introduction":"犀牛财经  专业财经新媒体","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2077,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>营收净利双增\n<br>【福元医药：上半年归母净利润2.91亿元，同比增16.1%】福元医药8月14日发布2024年半年度报告，公司2024年上半年实现营业收入16.55亿元，同比增长1.58%；归属于上市公司股东的净利润2.91亿元，同比增长16.10%；基本每股收益0.61元。</body></html>","htmlText":"<html><head></head><body>营收净利双增\n<br>【福元医药：上半年归母净利润2.91亿元，同比增16.1%】福元医药8月14日发布2024年半年度报告，公司2024年上半年实现营业收入16.55亿元，同比增长1.58%；归属于上市公司股东的净利润2.91亿元，同比增长16.10%；基本每股收益0.61元。</body></html>","text":"营收净利双增 【福元医药：上半年归母净利润2.91亿元，同比增16.1%】福元医药8月14日发布2024年半年度报告，公司2024年上半年实现营业收入16.55亿元，同比增长1.58%；归属于上市公司股东的净利润2.91亿元，同比增长16.10%；基本每股收益0.61元。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/338692608860384","repostId":0,"isVote":1,"tweetType":1,"viewCount":8,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":216,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/338692608860384"}